EcoR1 Capital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001587114

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q2 2024 · 55 positions · Total reported value $3.27B · Top-10 concentration 61.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.3% · 9 new · 5 cut · 7 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +32.8% · vs SPY +18.0% · Prev Value $2.12B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2024 13F filing, EcoR1 Capital, LLC disclosed 55 equity positions with a combined reported value of $3.27B. The filing implies a focused portfolio: its ten largest positions account for 61.4% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were APLS ($445.26M), PRTA ($239.10M), SRPT ($222.36M). By sector, the heaviest allocations are Health Care 62.3%, Materials 0.8%.

Versus the prior quarter, EcoR1 Capital, LLC opened 9 new positions, trimmed 5 and fully exited 7, a turnover rate of 55.3% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q2 2024 were JANX ($61.57M), CRGX ($24.14M), BCYC ($18.42M).

Of the 7 positions fully exited versus the prior quarter, the largest were ALEC ($24.42M), NKTX ($21.62M), OVID ($18.66M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • JANX JANUX THERAPEUTICS INC · $61.57M
  • CRGX CARGO THERAPEUTICS INC · $24.14M
  • BCYC BICYCLE THERAPEUTICS PLC · $18.42M
  • TECX TECTONIC THERAPEUTIC INCORPORATED · $13.99M
  • RCKT ROCKET PHARMACEUTICALS INC COM · $10.95M
  • REPL REPLIMUNE GROUP INC · $7.65M

Fully Exited (vs previous quarter)

  • ALEC ALECTOR INC COM · prev qtr: $24.42M
  • NKTX NKARTA INC · prev qtr: $21.62M
  • OVID OVID THERAPEUTICS INC · prev qtr: $18.66M
  • GOSS GOSSAMER BIO INC · prev qtr: $10.85M
  • ARQT ARCUTIS BIOTHERAPEUTICS INC · prev qtr: $4.96M
  • PMVP PMV PHARMACEUTICALS · prev qtr: $963.69K
  • KOD KODIAK SCIENCES INC · prev qtr: $268.79K
  • ALPN ALPINE IMMUNE SCIENCES INC · prev qtr: $39.64K

Insider Transactions (Form 4)

Latest EcoR1 Capital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-05-07 Buy Atara Biotherapeutics, Inc. 507,407 $9.35 SEC filing
2026-04-20 Sell First Tracks Biotherapeutics, Inc. 4,705,575 $13.81 SEC filing

All insider transactions →

Fund Profile

EcoR1 Capital, LLC, based in San Francisco, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 31 positions worth $1.95B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-100470 (status: Approved), registered 2015-07-02
  • Regulatory AUM (Form ADV): $3.42B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds

Portfolio Structure

  • 31 positions · $1.95B reported value (Q2 2026)
  • Top 10 holdings = 87.7% of reported value
  • Largest position: ZYME (ZYMEWORKS INC) at 30.8%
  • Average position size: $62.85M

Sector Tilt

  • Health Care 97.3%
  • Financials 0.1%
  • (classified holdings cover 97% of value)

Quarterly Activity

  • Q2 2026: 9 new, 2 added, 5 reduced, 7 exited
  • 15 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 62.3%
Materials 0.8%
Other 36.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 11.61M $445.26M 13.62%
13.62%
Add
2 11.58M $239.10M 7.31%
7.31%
Hold
3 1.41M $222.36M 6.80%
6.80%
Reduce
4 7.52M $188.48M 5.77%
5.77%
Hold
5 4.16M $186.12M 5.69%
5.69%
Hold
6 6.73M $179.06M 5.48%
5.48%
Hold
7 4.98M $169.77M 5.19%
5.19%
Add
8 5.76M $142.64M 4.36%
4.36%
Hold
9 5.81M $119.56M 3.66%
3.66%
Add
10 13.33M $114.38M 3.50%
3.50%
Hold
11 13.44M $114.35M 3.50%
3.50%
Hold
12 1.01M $108.22M 3.31%
3.31%
Hold
13 5.33M $100.90M 3.09%
3.09%
Hold
14 1.39M $75.03M 2.29%
2.29%
Hold
15 1.47M $61.57M 1.88%
1.88%
New
16 19.21M $56.09M 1.72%
1.72%
Hold
17 5.71M $51.60M 1.58%
1.58%
Add
18 3.25M $48.23M 1.48%
1.48%
Add
19 3.88M $46.94M 1.44%
1.44%
Hold
20 1.27M $46.26M 1.42%
1.42%
Hold
21 3.18M $41.37M 1.27%
1.27%
Hold
22 19.36M $38.92M 1.19%
1.19%
Hold
23 3.92M $30.99M 0.95%
0.95%
Hold
24 757.58K $30.95M 0.95%
0.95%
Hold
25 5.00M $29.25M 0.90%
0.90%
Hold
26 27.40M $26.72M 0.82%
0.82%
Hold
27 3.42M $24.17M 0.74%
0.74%
Hold
28 1.47M $24.14M 0.74%
0.74%
New
29 650.00K $24.06M 0.74%
0.74%
Hold
30 300.00K $22.65M 0.69%
0.69%
Hold
31 1.25M $22.52M 0.69%
0.69%
Hold
32 1.35M $21.88M 0.67%
0.67%
Reduce
33 1.22M $21.09M 0.65%
0.65%
Hold
34 75.00K $21.01M 0.64%
0.64%
Hold
35 2.07M $20.36M 0.62%
0.62%
Hold
36 910.00K $18.42M 0.56%
0.56%
New
37 5.44M $18.01M 0.55%
0.55%
Reduce
38 900.00K $16.92M 0.52%
0.52%
Hold
39 427.04K $15.07M 0.46%
0.46%
Hold
40 849.14K $13.99M 0.43%
0.43%
New
41 508.39K $10.95M 0.34%
0.34%
New
42 187.50K $8.57M 0.26%
0.26%
Hold
43 11.29M $8.17M 0.25%
0.25%
Hold
44 850.34K $7.65M 0.23%
0.23%
New
45 1.25M $6.10M 0.19%
0.19%
Hold
46 2.05M $5.77M 0.18%
0.18%
Hold
47 700.00K $3.60M 0.11%
0.11%
Hold
48 406.68K $3.46M 0.11%
0.11%
Reduce
49 2.04M $3.39M 0.10%
0.10%
Reduce
50 5.72M $3.38M 0.10%
0.10%
Add

FAQ

What did EcoR1 Capital, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, EcoR1 Capital, LLC reported 55 equity positions worth $3.27B in aggregate; its largest disclosed positions were APLS ($445.26M), PRTA ($239.10M), SRPT ($222.36M).

How large is EcoR1 Capital, LLC's portfolio?

EcoR1 Capital, LLC reported $3.27B of long equity holdings across 55 positions as of 2024-Q2. Top-10 holdings account for 61.4% of reported value.

What is EcoR1 Capital, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/ecor1-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →